Molecular Mechanism and Prediction of Sorafenib Chemoresistance in Human Hepatocellular Carcinoma

Publisher： Karger

E-ISSN： 1421-9875|33|6|771-779

ISSN： 0257-2753

Source： Digestive Diseases, Vol.33, Iss.6, 2015-0, pp. : 771-779

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

MicroRNAs for the Prediction of Early Response to Sorafenib Treatment in Human Hepatocellular Carcinoma

By  

Liver Cancer, Vol. 6, Iss. 2, 2016-12 ,pp. : 113-125

Karger

Access to resources Recommend Favorite

IGF-II Producing Hepatocellular Carcinoma Treated with Sorafenib: Metabolic Complications and a Foresight to Molecular Targeting Therapy to the IGF Signal

By  

Case Reports in Gastroenterology, Vol. 6, Iss. 3, 2012-12 ,pp. : 784-789

Karger

Access to resources Recommend Favorite

Molecular Pathogenesis of Hepatocellular Carcinoma

By  

Liver Cancer, Vol. 5, Iss. 4, 2016-09 ,pp. : 290-302

Karger

Access to resources Recommend Favorite

Safety and tolerance of sorafenib in Japanese patients with advanced hepatocellular carcinoma

By Ogasawara Sadahisa  

Hepatology International, Vol. 5, Iss. 3, 2011-09 ,pp. : 850-856

Springer Publishing Company

Access to resources Recommend Favorite

Safety of transarterial chemoembolization plus sorafenib combination treatment in unresectable hepatocellular carcinoma

By Sinakos Emmanouil   Dedes Ioannis   Papalavrentios Lavrentis   Drevelegas Antonios   Akriviadis Evangelos  

Scandinavian Journal of Gastroenterology, Vol. 45, Iss. 4, 2010-04 ,pp. : 511-512

Informa Healthcare

Access to resources Recommend Favorite